Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Monroe

Showing results (331-340 of 425) with videos related to

Pageof 43
Sort By:
Recent Patents on Food, Nutrition & Agriculture|July 27, 2010
Patents on periphery of the Amazon rainforestEmanoel G de Moura, José R G Araújo, Paulo H M Monroe, et al.
Biochemistry|May 16, 1998
Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesiclesP J Larson, R M Camire, D Wong, et al.
Archives of Biochemistry and Biophysics|April 1, 1994
Spin trapping of azidyl and hydroxyl radicals in azide-inhibited rat brain submitochondrial particlesR S Partridge, S M Monroe, J K Parks, et al.
Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Journal of Medical Internet Research|June 15, 2016
A Technology-Mediated Behavioral Weight Gain Prevention Intervention for College Students: Controlled, Quasi-Experimental StudyDelia Smith West, Courtney M Monroe, Gabrielle Turner-McGrievy, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular riskAllan D Sniderman, Ken Williams, John H Contois, et al.
Journal of Thrombosis and Haemostasis : JTH|April 16, 2013
Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levelsY Dargaud, M Hoffman, L Lefrapper, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2020
Computationally Driven Discovery in CoagulationKathryn G Link, Michael T Stobb, Dougald M Monroe, et al.
Blood|May 1, 1989
Functional consequences of an arginine180 to glutamine mutation in factor IX HiloD M Monroe, D M McCord, M N Huang, et al.
Leukemia & Lymphoma|March 13, 2023
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemiaMatteo Passerini, Tamar Ratishvili, Jonathon M Monroe, et al.
Pageof 43

Showing results (331-340 of 425) with videos related to

Sort By:
Pageof 43
Recent Patents on Food, Nutrition & Agriculture|July 27, 2010
Patents on periphery of the Amazon rainforestEmanoel G de Moura, José R G Araújo, Paulo H M Monroe, et al.
Biochemistry|May 16, 1998
Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesiclesP J Larson, R M Camire, D Wong, et al.
Archives of Biochemistry and Biophysics|April 1, 1994
Spin trapping of azidyl and hydroxyl radicals in azide-inhibited rat brain submitochondrial particlesR S Partridge, S M Monroe, J K Parks, et al.
Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Journal of Medical Internet Research|June 15, 2016
A Technology-Mediated Behavioral Weight Gain Prevention Intervention for College Students: Controlled, Quasi-Experimental StudyDelia Smith West, Courtney M Monroe, Gabrielle Turner-McGrievy, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular riskAllan D Sniderman, Ken Williams, John H Contois, et al.
Journal of Thrombosis and Haemostasis : JTH|April 16, 2013
Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levelsY Dargaud, M Hoffman, L Lefrapper, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2020
Computationally Driven Discovery in CoagulationKathryn G Link, Michael T Stobb, Dougald M Monroe, et al.
Blood|May 1, 1989
Functional consequences of an arginine180 to glutamine mutation in factor IX HiloD M Monroe, D M McCord, M N Huang, et al.
Leukemia & Lymphoma|March 13, 2023
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemiaMatteo Passerini, Tamar Ratishvili, Jonathon M Monroe, et al.
Pageof 43